drugset / Trial / NCT03079999
Study of Aspirin in Patients With Vestibular Schwannoma
Phase 2
Active not recruiting
97 enrolled
Massachusetts Eye and Ear Infirmary
United States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
Timeline
- Start
- 2018-06-11
- Primary completion
- 2026-08
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Aspirin | Small molecule | 325 mg | — |